Progyny, Inc. (PGNY) financials: revenue, earnings and cash flow
Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Progyny’s revenue went from $49M in fiscal 2017 to $1.3B in fiscal 2025, growth of about 50.6% a year.
Net income in fiscal 2025 was $59M, a net margin of 4.5%; the best year in this period was 2021 with $66M.
Over the twelve months to September 30, 2026, revenue was $1.3B and net income $91M.
Free cash flow was $192M in fiscal 2025 and positive in 7 of the 9 years shown.
The diluted share count rose 1483% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.2B | $1.1B | $787M | $501M | $345M | $230M | $105M | $49M |
| Gross profit | $333M | $304M | $253M | $239M | $167M | $112M | $70M | $46M | $19M | $7M |
| Operating income | $126M | $85M | $67M | $62M | $23M | $32M | $8M | $10M | -$3M | -$11M |
| Net income | $91M | $59M | $54M | $62M | $30M | $66M | $46M | -$9M | $661000 | -$12M |
| EPS (diluted) | $1.09 | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 | $0.47 | $-0.41 | $0.04 | $-2.37 |
| R&D | $12M | $10M | — | — | — | — | — | — | — | — |
| Revenue growth | — | +10.4% | +7.2% | +38.3% | +57.2% | +45.2% | +50.1% | +117.9% | +116.9% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $207M | $210M | $179M | $189M | $80M | $26M | $36M | -$2M | $2M | -$9M |
| Capital spending | -$28M | -$18M | -$5M | -$4M | -$3M | -$2M | -$1M | -$3M | -$579000 | -$612000 |
| Free cash flow | $180M | $192M | $174M | $185M | $77M | $24M | $35M | -$4M | $2M | -$10M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $313M | $82M | $300M | $0 | $0 | — | — | $185000 | $1M | — |
| Stock-based pay | $96M | $132M | $128M | $123M | $101M | $34M | $13M | $5M | $3M | $2M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $310M | $228M | $371M | $189M | $119M | $109M | $80M | $127000 | — |
| Debt | — | $28M | $19M | $19M | $8M | $9M | $10M | $10M | $253000 | — |
| Equity | — | $516M | $422M | $553M | $377M | $252M | $167M | $114M | -$95M | -$98M |
| Total assets | — | $742M | $607M | $757M | $543M | $358M | $254M | $150M | $41M | — |
| Shares (diluted) | 81M | 90M | 95M | 101M | 100M | 100M | 99M | 21M | 6M | 6M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 24.9% | 23.6% | 21.7% | 21.9% | 21.3% | 22.4% | 20.3% | 19.8% | 18.4% | 15.2% |
| Operating margin | 9.4% | 6.6% | 5.8% | 5.7% | 3.0% | 6.5% | 2.4% | 4.2% | -3.3% | -22.7% |
| Net margin | 6.8% | 4.5% | 4.7% | 5.7% | 3.9% | 13.1% | 13.5% | -3.7% | 0.6% | -25.6% |
| FCF margin | 13.4% | 14.9% | 14.9% | 17.0% | 9.8% | 4.8% | 10.2% | -1.9% | 1.6% | -20.8% |
| ROIC | — | 9.6% | 10.0% | 9.5% | 4.8% | 9.8% | 3.7% | 6.2% | — | — |
| ROE | — | 11.3% | 12.9% | 11.2% | 8.1% | 26.1% | 27.8% | -7.5% | -0.7% | 12.8% |
Frequently asked questions
What is Progyny’s annual revenue?
$1.3B in fiscal 2025 and $1.3B over the twelve months to September 30, 2026.
How much profit does Progyny make?
Net income was $59M in fiscal 2025 (net margin 4.5%).
Is Progyny’s revenue growing?
Yes: revenue rose 10.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.